June 1, 2016
Via: Mass DeviceBioventrix said today it won FDA investigational device exemption approval to initiate a pivotal trial of its Revivent TC transcatheter ventricular enhancement system device designed for reshaping and restoring the left ventricle. Revivent is designed to eliminate the need for […]
November 30, 2023
November 28, 2023
November 21, 2023
November 16, 2023
November 14, 2023
November 7, 2023
November 2, 2023